BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 37060880)

  • 1. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
    Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
    Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.
    Nazir J; Hakimi Z; Guelfucci F; Khemiri A; Fatoye F; Blázquez AMM; González MH
    BMC Urol; 2018 Sep; 18(1):76. PubMed ID: 30180826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.
    Kao LT; Huang CY; Lin HC; Chu CM
    J Clin Pharmacol; 2018 Jun; 58(6):727-732. PubMed ID: 29315618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study.
    Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
    J Gen Intern Med; 2020 Jul; 35(7):2084-2093. PubMed ID: 32026255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder.
    Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
    Int J Geriatr Psychiatry; 2021 May; 36(5):684-696. PubMed ID: 33169433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.
    Vouri SM; Kebodeaux CD; Stranges PM; Teshome BF
    Arch Gerontol Geriatr; 2017; 69():77-96. PubMed ID: 27889591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study.
    Sanjinez C; Botteri E; Støer NC; Lukas Löfling L
    Lung Cancer; 2023 May; 179():107187. PubMed ID: 37060880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics.
    Wagg A; Nitti VW; Kelleher C; Castro-Diaz D; Siddiqui E; Berner T
    Curr Med Res Opin; 2016; 32(4):621-38. PubMed ID: 26828974
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.